Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Biochemical Pharmacology|June 15, 1988
Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human plateletsA W Simpson, M L Reeves, T J RinkDiabetes Care|May 1, 1982
Lack of effect of improved glycemic control on C-peptide secretion in patients without residual B-cell functionD E Seigler, M L Reeves, J S SkylerCellular Signalling|January 1, 1992
Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cellsC Schmitz-Peiffer, M L Reeves, R M DentonMolecular and Cellular Biochemistry|September 7, 1989
Protein phosphorylation and compartments of cyclic AMP in the control of cardiac contractionK J Murray, M L Reeves, P J EnglandThe Biochemical Journal|January 15, 1987
The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitorsM L Reeves, B K Leigh, P J EnglandDiabetes Care|May 1, 1982
A comparison of insulin regimens in insulin-dependent diabetes mellitusJ S Skyler, D E Seigler, M L ReevesThe American Journal of Medicine|April 1, 1982
Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusionM L Reeves, D E Seigler, E A Ryan, et al.The American Journal of Medicine|May 1, 1984
Medial plantar sensory response. Sensitive indicator of peripheral nerve dysfunction in patients with diabetes mellitusM L Reeves, D E Seigler, D R Ayyar, et al.Journal of Medicinal Chemistry|June 1, 1990
1,4-bis(3-oxo-2,3-dihydropyridazin-6-yl)benzene analogues: potent phosphodiesterase inhibitors and inodilatorsW J Coates, H D Prain, M L Reeves, et al.Pageof 2